CASP3 and neoplasm: In mice, the combination of Valiparib and oxaliplatin also led to the significant suppression of MAEA-overexpressing subcutaneous tumor growth (Fig. 7G) with concomitant changes in Ki67 and cleaved caspase-3 (Fig. 7H) staining in tumors from these animals.